S&P 500
(1.02%) 5 099.96 points
Dow Jones
(0.40%) 38 240 points
Nasdaq
(2.03%) 15 928 points
Oil
(0.11%) $83.66
Gas
(-3.32%) $1.920
Gold
(0.30%) $2 349.60
Silver
(-0.43%) $27.52
Platinum
(0.42%) $924.40
USD/EUR
(0.32%) $0.935
USD/NOK
(0.67%) $11.02
USD/GBP
(0.13%) $0.800
USD/RUB
(-0.07%) $92.11

实时更新: ASLAN Pharmaceuticals [ASLN]

交易所: NASDAQ 部门: Healthcare 工业: Biotechnology
最后更新时间27 Apr 2024 @ 04:00

-7.30% $ 0.415

Live Chart Being Loaded With Signals

Commentary (27 Apr 2024 @ 04:00):

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients...

Stats
今日成交量 641 108
平均成交量 1.22M
市值 7.88M
EPS $-0.780 ( 2024-04-26 )
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E -0.150
ATR14 $0.00600 (1.43%)

音量 相关性

長: -0.09 (neutral)
短: -0.89 (strong negative)
Signal:(41.071) Neutral

ASLAN Pharmaceuticals 相关性

10 最正相关
TYRA0.946
RCEL0.946
SHIP0.943
ASUR0.943
XLRN0.942
OPRA0.94
AMPH0.939
RDNT0.934
FLMN0.934
LFMDP0.933
10 最负相关
GOODN-0.944
WISH-0.943
TBIO-0.935
TREE-0.934
UPLD-0.931
MICS-0.929
GMVD-0.927
AVGR-0.925
BAND-0.925
GOODO-0.924

你知道吗?

相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。

相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。

ASLAN Pharmaceuticals 相关性 - 货币/商品

The country flag 0.00
( neutral )
The country flag 0.10
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag 0.00
( neutral )
The country flag -0.15
( neutral )

ASLAN Pharmaceuticals 财务报表

Annual 2023
营收: $12.00M
毛利润: $11.65M (97.10 %)
EPS: $-2.69
FY 2023
营收: $12.00M
毛利润: $11.65M (97.10 %)
EPS: $-2.69
FY 2022
营收: $0
毛利润: $-331 752 (0.00 %)
EPS: $-3.68
FY 2021
营收: $0.00
毛利润: $0.00 (0.00 %)
EPS: $-0.815

Financial Reports:

No articles found.

ASLAN Pharmaceuticals

ASLAN Pharmaceuticals Limited, a clinical-stage immunology focused biopharmaceutical company, engages in developing various treatments to transform the lives of patients. The company's clinical portfolio comprises ASLAN004, a monoclonal therapy that is being developed in atopic dermatitis and other immunology indications; and ASLAN003, a small-molecule inhibitor of dihydroorotate dehydrogenase for the treatment of autoimmune conditions. It has a joint venture with JAGUAHR Therapeutics Pte. Ltd. and Bukwang Pharmaceutical Co., Ltd. to develop immuno-oncology therapeutics for markets targeting the AhR pathway. Its partners include Almirall, Array BioPharma, and CSL Limited. The company was founded in 2010 and is headquartered in Singapore.

关于 实时信号

此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。

实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。